Neoadjuvant chemoradiotherapy for patients with squamous cell carcinoma of the oesophagus

被引：0
|
作者：
Pereira, AD
Gloria, L
Claro, I
Chagas, C
Oliveira, J
Vaz, F
Rodrigues, R
Almeida, JC
Leitao, CN
Almeida, JM
Fernandes, A
Mira, FC
机构：
[1] INST PORTUGUES ONCOL LISBOA,DEPT GASTROENTEROL,LISBON,PORTUGAL
[2] INST PORTUGUES ONCOL LISBOA,DEPT SURG,LISBON,PORTUGAL
[3] INST PORTUGUES ONCOL LISBOA,DEPT RADIOTHERAPY & ONCOL,LISBON,PORTUGAL
来源：
GUT | 1997年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A156 / A156
页数：1
相关论文
共 50 条
  • [1] Single Unit Experience of Neoadjuvant Chemoradiotherapy (CROSS) in Patients with Squamous Carcinoma of the Oesophagus
    Enein, Mohamed Aboul
    Qureshi, Asad
    Davies, Andrew
    Baker, Cara
    Kelly, Mark
    Gossage, James
    BRITISH JOURNAL OF SURGERY, 2018, 105 : 33 - 33
  • [2] Neoadjuvant chemoradiotherapy in carcinoma of the oesophagus.
    Toy, EW
    Crosby, TD
    Bowrey, DJ
    Clark, GW
    Carey, PD
    Maughan, TS
    BRITISH JOURNAL OF CANCER, 1998, 78 : 22 - 22
  • [3] Definitive and neoadjuvant radiochemotherapy of squamous cell carcinoma of the oesophagus
    Fietkau, R
    ONKOLOGIE, 2004, 27 (01): : 39 - 44
  • [4] Neoadjuvant Chemotherapy Versus Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma
    Nakashima, Yuichiro
    Saeki, Hiroshi
    Hu, Qingjiang
    Tsuda, Yasuo
    Hisamatsu, Yuichi
    Ando, Koji
    Oki, Eiji
    Maehara, Yoshihiko
    ANTICANCER RESEARCH, 2018, 38 (12) : 6809 - 6814
  • [5] Neoadjuvant chemoradiotherapy with camrelizumab in patients with locally advanced esophageal squamous cell carcinoma
    Chen, Fei
    Qiu, Lingdong
    Mu, Yushu
    Sun, Shibin
    Yuan, Yulong
    Shang, Pan
    Ji, Bo
    Wang, Qifei
    FRONTIERS IN SURGERY, 2022, 9
  • [6] Prognostic benefit of surgery following chemoradiotherapy for squamous cell carcinoma of the oesophagus
    McGlone, Emma R.
    Khan, Omar A.
    INTERNATIONAL JOURNAL OF SURGERY, 2012, 10 (07) : 341 - 344
  • [7] Survival after neoadjuvant chemoradiotherapy and oesophagectomy versus definitive chemoradiotherapy for patients with oesophageal squamous cell carcinoma
    Wang, B. -Y.
    Wu, S. -C.
    Chen, H. -C.
    Hung, W. -H.
    Lin, C. -H.
    Huang, C. -L.
    Chen, H. -S.
    BRITISH JOURNAL OF SURGERY, 2019, 106 (03) : 255 - 262
  • [8] Definitive Chemoradiotherapy versus neoadjuvant Chemoradiotherapy and Resection for Squamous Cell Carcinoma of the Esophagus
    Schrempf, M.
    Anthuber, M.
    CHIRURG, 2019, 90 (03): : 239 - 239
  • [9] Neoadjuvant Chemoradiotherapy vs Chemoimmunotherapy for Esophageal Squamous Cell Carcinoma
    Guo, Xufeng
    Chen, Chunji
    Zhao, Jinbo
    Wang, Changchun
    Mei, Xinyu
    Shen, Jianfei
    Lv, Huilai
    Han, Yongtao
    Wang, Qifeng
    Lv, Jiahua
    Chen, Hainan
    Yan, Xiaolong
    Liu, Zhichao
    Zhang, Zhengyang
    Zhong, Qihong
    Jiang, Youhua
    Xu, Liwei
    Li, Xiaoyang
    Qian, Dong
    Ma, Dehua
    Ye, Minhua
    Wang, Chunguo
    Wang, Zimin
    Lin, Jiangbo
    Tian, Ziqiang
    Leng, Xuefeng
    Li, Zhigang
    JAMA SURGERY, 2025,
  • [10] Dosiomics and Radiomics Guided Precision Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Carcinoma Patients
    Cui, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E112 - E113
12345